Literature DB >> 28883261

Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.

Ayana Suzuki1, Mitsuyoshi Hirokawa2, Nami Takada1, Miyoko Higuchi1, Aki Ito1, Naoki Yamao1, Toshitetsu Hayashi2, Seiji Kuma2, Akira Miyauchi3.   

Abstract

Many cytological studies on medullary thyroid carcinoma (MTC) have been reported; however, such studies in large series of patients with MTC have not been performed. We investigated MTC at a single institution in Japan using fine-needle aspiration cytology (FNAC), and aimed to establish a preoperative diagnostic algorithm for MTC. FNAC was performed in 119 of 149 patients with MTC (79.9%) who ultimately underwent surgical resection. Moreover, 22 of 56 hereditary MTC (39.3%) were diagnosed preoperatively without FNAC by their high serum calcitonin levels or increased response to calcium stimulation (11 cases each), as well as RET mutation analysis. On FNAC, 76.5% of nodules were categorized as 'malignancy' or 'suspicious for malignancy'. The sensitivity and specificity of calcitonin measurement in aspiration needle wash-out fluid and in immunocytochemical staining for calcitonin were 96.3% and 92.3% respectively. We proposed an algorithm for preoperative diagnosis of MTC utilizing FNAC: When thyroid nodules are highly suspicious for MTC by their clinical and ultrasonographic features, serum calcitonin measurement with or without a calcium stimulation test is required. Furthermore, FNAC should be performed for patients who do not have those findings. When there is a possibility of MTC at the time of FNAC, calcitonin measurement using needle wash-out fluid is a reliable diagnostic tool. When MTC is suspected on cytological examination, immunocytochemical staining for calcitonin is useful for confirming MTC diagnosis.

Entities:  

Keywords:  Calcitonin; Fine-needle aspiration cytology; Immunocytochemical staining; Medullary thyroid carcinoma; Needle wash-out fluid

Mesh:

Substances:

Year:  2017        PMID: 28883261     DOI: 10.1507/endocrj.EJ17-0238

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

1.  Calcitonin Screening in Nodular Thyroid Disease: Is There a Definitive Answer?

Authors:  Catarina Silvestre; Joaquim Sampaio Matias; Helena Proença; Maria João Bugalho
Journal:  Eur Thyroid J       Date:  2018-12-05

2.  Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration.

Authors:  Bernardo Marques; Nuno Cunha; Raquel G Martins; Ana Rita Elvas; Joana Couto; Jacinta Santos; Teresa Martins; Ana Paula Moniz; Olga Ilhéu; Frederico Valido; Fernando Rodrigues
Journal:  Int J Endocrinol       Date:  2020-04-04       Impact factor: 3.257

3.  Calcitonin measurement in fine-needle aspirate washout fluid by electrochemiluminescence immunoassay for thyroid tumors.

Authors:  Minoru Kihara; Mitsuyoshi Hirokawa; Takumi Kudo; Toshitetsu Hayashi; Masatoshi Yamamoto; Hiroo Masuoka; Takuya Higashiyama; Mitsuhiro Fukushima; Yasuhiro Ito; Akihiro Miya; Akira Miyauchi
Journal:  Thyroid Res       Date:  2018-10-30

4.  Calcitonin-secreting pancreatic neuroendocrine tumor in a patient with elevated thyroid fine-needle aspirate calcitonin washout: A case report and review of the literature.

Authors:  Darryl Mason; Robert Leimbach; Robert Kitz; Robert Vietor; Nicole Vietor
Journal:  Clin Case Rep       Date:  2022-01-24

5.  The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology.

Authors:  Muhammed Erkam Sencar; Sema Hepsen; Murat Çalapkulu; Hayri Bostan; Davut Sakiz; Ilknur Ozturk Unsal; Hakan Duger; Muhammed Kizilgul; Bekir Ucan; Tugba Taskin Turkmenoglu; Mustafa Ozbek; Erman Cakal
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.